Visiting Professor, Glenn Center for the Biology of Human Aging, Albert Einstein College of Medicine
Affiliate Member, Dept. of Human Evolutionary Biology, Harvard University
Dr. Diddahally (Raju) Govindaraju has over thirty years of experience in genetics research both in academia and in the biotech industry. His expertise spans over several areas: quantitative, population, molecular, medical and evolutionary genetics, and has published widely in these areas. He pioneered the use of haplotype-centered approaches in pharmacogenetics and nutritional genomics at Genaissance, Variagenics and Interleukin Genetics companies. Later he served as a Senior Director at Galileo Genomics, which performed the world’s first comprehensive GWAS in 2004, and discovered many genes associated with Crohn’s disease in the French-Canadian founder population. Subsequently, he worked as an Associate Professor at Boston University School of Medicine, during which he played a catalytic role toward a synthesis of Evolution in Health and Medicine through the National Academy of Sciences and the Institute of Medicine. Together with three colleagues, he demonstrated that despite medical advances humans are still evolving, solving a 150 year-old conjecture.
He is currently working on human aging, using an integrated genome-phenome map, demographic and He is currently working on human aging, using an integrated genome-phenome map, demographic and systems approaches. He is interested in understanding the role of genome instability in, and evolutionary bases of, extreme health and longevity, as well as how and why evolutionary ideas are important in human health. He received his Master’s degree and medical genetics training at Yale University and Ph.D. from Rutgers University.